Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones

被引:34
作者
Brostjan, C
Bellón, T
Sobanov, Y
López-Botet, M
Hofer, E
机构
[1] Univ Vienna, VIRCC, Dept Vasc Biol & Thrombosis Res, A-1235 Vienna, Austria
[2] Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria
[3] Hosp Univ Princesa, Serv Immunol, Madrid, Spain
[4] Univ Pompeu Fabra, DCEXS Inmunol, Barcelona, Spain
关键词
natural killer cell; NK receptor; NKG2; real-time PCR; transcript; clonal expression;
D O I
10.1016/S0022-1759(02)00084-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Natural killer cells are known to express a variety of surface receptors involved in HLA class I monitoring. It is thus of interest to investigate the clonal distribution and relative expression levels of activating versus inhibitory NK receptors, We have developed a quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) assay designed to determine specific and absolute mRNA levels for NKG2-A/B, -C, -E, -F, -H and NKG2-D, When analyzing NK cell clones derived from a single donor we found differential expression of inhibitory (NKG2-A/B) versus triggering (NKG2-C and potentially -E, -F, -H) NK receptor chains. The generation of the splice variants NKG2-E and -H seemed to occur at a constant ratio. We further compared NKG2 transcript levels to surface receptor expression as monitored by flow cytometric analysis and to NK cell cytotoxicity as detected by reverse ADCC: a clear correlation was observed. Thus, the data obtained reveal a substantial variability in the NKG2 repertoire among NK cell subpopulations, which is likely to affect the sensitivity and reactivity towards the ligand HLA-E. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 51 条
[1]  
Andersson M, 1998, J IMMUNOL, V161, P6475
[2]  
ARAMBURU J, 1990, J IMMUNOL, V144, P3238
[3]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[4]  
Bellón T, 1999, J IMMUNOL, V162, P3996
[5]   Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients [J].
Besostri, B ;
Beggiato, E ;
Bianchi, A ;
Mariani, S ;
Coscia, M ;
Peola, S ;
Foglietta, M ;
Boccadoro, M ;
Pileri, A ;
Moretta, L ;
Massaia, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :46-53
[6]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[7]  
Braud VM, 1999, CURR TOP MICROBIOL, V244, P85
[8]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[9]   NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor [J].
Brooks, AG ;
Posch, PE ;
Scorzelli, CJ ;
Borrego, F ;
Coligan, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :795-800
[10]   The NKG2 natural killer cell receptor family: comparative analysis of promoter sequences [J].
Brostjan, C ;
Sobanov, Y ;
Glienke, J ;
Hayer, S ;
Lehrach, H ;
Francis, F ;
Hofer, E .
GENES AND IMMUNITY, 2000, 1 (08) :504-508